← Back to Search

Behavioral Intervention

Financial Incentives for Smoking Cessation (Aniqsaaq-RCT Trial)

N/A

Recruiting

Led By Christi A Patten, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Index Participant: Age ≥18 years

Index Participant: Smoked ≥ 3 cigarettes per day over the past 3 months

Must not have

Index Participant: Self-report current marijuana smoking more than once per week and are not willing to quit for the study duration

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months, 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if a program that rewards families for quitting smoking is effective for Alaska Native/American Indian families. They will compare families in the program to those not in the program to see if they

Who is the study for?

This trial is for Alaska Native/American Indian families looking to quit smoking. Participants must meet certain criteria, but specific inclusion and exclusion details are not provided.

What is being tested?

The study tests if offering financial rewards helps families stop smoking. It's a randomized controlled trial comparing this approach with a control group, checking results at 6 and 12 months after the intervention.

What are the potential side effects?

Since the intervention involves financial incentives rather than medical treatment, there are no direct side effects like those associated with drugs or medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have smoked at least 3 cigarettes daily for the last 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I smoke marijuana more than once a week and don't plan to quit for the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in smoking status

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Rewards GroupExperimental Treatment1 Intervention

Index participants in the Rewards Group will be scheduled to complete smoking status check-ins six times during the 6-month Treatment Phase: weekly for four weeks, then at three and six months. At each check-in, cigarette smoking abstinence will be assessed. Participants in the Rewards Group will receive informational materials on smoking cessation.

Group II: Comparison GroupActive Control1 Intervention

Index participants in the Comparison Group will be scheduled to complete smoking status check-ins six times during the 6-month Treatment Phase: weekly for four weeks, then at three and six months. At each check-in, cigarette smoking abstinence will be assessed. Participants in the Comparison Group will receive informational materials on smoking cessation.

0 / 3Eligibility criteria met